XML 39 R6.htm IDEA: XBRL DOCUMENT v3.24.2
Unaudited Condensed Consolidated Statements of Change in Stockholders’ Equity (Deficiency) - USD ($)
Common Stock
Previously Reported
Common Stock
Additional Paid in Capital
Previously Reported
Additional Paid in Capital
Accumulated Deficit
Previously Reported
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Total
Balance at Jun. 30, 2021   $ 103   $ 1,504,950   $ (7,969,726)   $ (55,580)   $ (6,520,253)
Balance (in Shares) at Jun. 30, 2021   10,312,585                
Beneficial conversion feature from issuance of convertible notes     1,231,610       1,231,610
Net loss       (11,746,014)     (11,746,014)
Issuance of common stock - non-employee stock compensation   $ 2   1,283,992       1,283,994
Issuance of common stock - non-employee stock compensation (in Shares)   232,666                
Foreign currency translation adjustments         154,104   154,104
Balance at Jun. 30, 2022 $ 105 $ 105 $ 4,020,552 4,020,552 $ (19,715,740) (19,715,740) $ 98,524 98,524 $ (15,596,559) (15,596,559)
Balance (in Shares) at Jun. 30, 2022 10,545,251 150,647 [1]             10,545,251  
Beneficial conversion feature from issuance of convertible notes     537,383       537,383
Net loss       (3,672,348)     (3,672,348)
Issuance of common stock - non-employee stock compensation   $ 1   439,331   0     439,332
Issuance of common stock - non-employee stock compensation (in Shares) [1]   1,570                
Conversion of convertible note payable   $ 38   14,097,376       14,097,414
Conversion of convertible note payable (in Shares) [1]   54,609                
Conversion of convertible note payable, related parties   $ 4   2,437,570       2,437,574
Conversion of convertible note payable, related parties (in Shares) [1]   5,047                
Issuance of common stock in initial public offering, net of issuance costs   $ 23   7,951,202       7,951,225
Issuance of common stock in initial public offering, net of issuance costs (in Shares) [1]   32,858                
Fair value of warrants issued in initial public offering     175,349       175,349
Issuance of warrants - non- employee stock compensation     856,170       856,170
Cashless exercise of warrants- non- employee stock compensation into common stock   $ 2   (2)      
Cashless exercise of warrants- non- employee stock compensation into common stock (in Shares) [1]   2,245                
Foreign currency translation adjustments         (135,276)   (135,276)
Balance at Sep. 30, 2022   $ 173   30,514,931   (23,388,088)   (36,752)   7,090,264
Balance (in Shares) at Sep. 30, 2022 [1]   246,976                
Balance at Jun. 30, 2022 $ 105 $ 105 4,020,552 4,020,552 (19,715,740) (19,715,740) 98,524 98,524 $ (15,596,559) (15,596,559)
Balance (in Shares) at Jun. 30, 2022 10,545,251 150,647 [1]             10,545,251  
Net loss                   (8,610,581)
Balance at Mar. 31, 2023   $ 176   30,896,963   (28,326,321)   (11,375)   2,559,443
Balance (in Shares) at Mar. 31, 2023 [1]   251,058                
Balance at Jun. 30, 2022 $ 105 $ 105 4,020,552 4,020,552 (19,715,740) (19,715,740) 98,524 98,524 $ (15,596,559) (15,596,559)
Balance (in Shares) at Jun. 30, 2022 10,545,251 150,647 [1]             10,545,251  
Beneficial conversion feature from issuance of convertible notes     749,062       749,062
Net loss       (11,727,711)     (11,727,711)
Issuance of common stock - non-employee stock compensation   $ 4   819,328       819,332
Issuance of common stock - non-employee stock compensation (in Shares)   395,547                
Conversion of convertible note payable   $ 42   14,476,325       14,476,367
Conversion of convertible note payable (in Shares)   4,150,140                
Conversion of convertible note payable, related parties   $ 4   2,437,570       2,437,574
Conversion of convertible note payable, related parties (in Shares)   353,272                
Issuance of common stock in initial public offering, net of issuance costs   $ 23   7,951,202       7,951,225
Issuance of common stock in initial public offering, net of issuance costs (in Shares)   2,300,000                
Fair value of warrants issued in initial public offering     175,349       175,349
Issuance of warrants - non- employee stock compensation     856,170       856,170
Cashless exercise of warrants- non- employee stock compensation into common stock   $ 2   (2)      
Cashless exercise of warrants- non- employee stock compensation into common stock (in Shares)   157,143                
Foreign currency translation adjustments         (271,141)   (271,141)
Balance at Jun. 30, 2023 $ 180 $ 180 31,485,556 31,485,556 (31,443,451) (31,443,451) (172,617) (172,617) $ (130,332) $ (130,332)
Balance (in Shares) at Jun. 30, 2023 17,901,353 255,734 [1]             17,901,353 255,734 [2]
Balance at Sep. 30, 2022   $ 173   30,514,931   (23,388,088)   (36,752)   $ 7,090,264
Balance (in Shares) at Sep. 30, 2022 [1]   246,976                
Net loss       (2,012,165)     (2,012,165)
Foreign currency translation adjustments           49,998   49,998
Balance at Dec. 31, 2022   $ 173   30,514,931   (25,400,253)   13,246   5,128,097
Balance (in Shares) at Dec. 31, 2022 [1]   246,976                
Beneficial conversion feature from issuance of convertible notes     2,035       2,035
Net loss       (2,926,068)     (2,926,068)
Issuance of common stock - non-employee stock compensation   $ 3   379,997   0     380,000
Issuance of common stock - non-employee stock compensation (in Shares) [1]   4,082                
Foreign currency translation adjustments         (24,621)   (24,621)
Balance at Mar. 31, 2023   $ 176   30,896,963   (28,326,321)   (11,375)   2,559,443
Balance (in Shares) at Mar. 31, 2023 [1]   251,058                
Balance at Jun. 30, 2023 $ 180 $ 180 31,485,556 31,485,556 (31,443,451) (31,443,451) (172,617) (172,617) $ (130,332) $ (130,332)
Balance (in Shares) at Jun. 30, 2023 17,901,353 255,734 [1]             17,901,353 255,734 [2]
Net loss       (2,131,712)     $ (2,131,712)
Conversion of convertible note payable   $ 28   1,325,610       1,325,638
Conversion of convertible note payable (in Shares) [1]   40,322                
Foreign currency translation adjustments         43   43
Balance at Sep. 30, 2023   $ 208   32,811,166   (33,575,163)   (172,574)   (936,363)
Balance (in Shares) at Sep. 30, 2023 [1]   296,056                
Balance at Jun. 30, 2023 $ 180 $ 180 $ 31,485,556 31,485,556 $ (31,443,451) (31,443,451) $ (172,617) (172,617) $ (130,332) $ (130,332)
Balance (in Shares) at Jun. 30, 2023 17,901,353 255,734 [1]             17,901,353 255,734 [2]
Net loss                   $ (5,044,541)
Balance at Mar. 31, 2024   $ 913   39,655,509   (36,487,992)   (97,961)   $ 3,070,469
Balance (in Shares) at Mar. 31, 2024   1,304,699 [1]               1,304,699 [2]
Balance at Sep. 30, 2023   $ 208   32,811,166   (33,575,163)   (172,574)   $ (936,363)
Balance (in Shares) at Sep. 30, 2023 [1]   296,056                
Net loss       (1,199,514)     (1,199,514)
Issuance of common stock to related parties for debts cancellation   $ 18   321,544       321,562
Issuance of common stock to related parties for debts cancellation (in Shares) [1]   25,954                
Issuance of common stock for acquiring intangible assets   $ 129   1,562,871       1,563,000
Issuance of common stock for acquiring intangible assets (in Shares) [1]   184,901                
Issuance of common stock and prefunded warrants in underwritten public offering, net of issuance costs   $ 260   3,457,046       3,457,306
Issuance of common stock and prefunded warrants in underwritten public offering, net of issuance costs (in Shares) [1]   371,629                
Exercise of prefunded warrants into common stock   $ 58   522       580
Exercise of prefunded warrants into common stock (in Shares) [1]   82,858                
Conversion of convertible note payable   $ 19   485,413       485,432
Conversion of convertible note payable (in Shares) [1]   27,739                
Foreign currency translation adjustments         (5,293)   (5,293)
Balance at Dec. 31, 2023   $ 692   38,638,562   (34,774,677)   (177,867)   3,686,710
Balance (in Shares) at Dec. 31, 2023 [1]   989,137                
Net loss       (1,713,315)     (1,713,315)
Issuance of common stock for acquiring intangible assets   $ 139   999,861       1,000,000
Issuance of common stock for acquiring intangible assets (in Shares) [1]   198,412                
Capital contribution     16,348       16,348
Additonal shares of common stock round up adjustment due to retroactive effect of 1-for-70 reverse stock split          
Additonal shares of common stock round up adjustment due to retroactive effect of 1-for-70 reverse stock split (in Shares) [1]   8                
Exercise of prefunded warrants into common stock   $ 82   738       820
Exercise of prefunded warrants into common stock (in Shares) [1]   117,142                
Foreign currency translation adjustments         79,906   79,906
Balance at Mar. 31, 2024   $ 913   $ 39,655,509   $ (36,487,992)   $ (97,961)   $ 3,070,469
Balance (in Shares) at Mar. 31, 2024   1,304,699 [1]               1,304,699 [2]
[1] Giving retroactive effect to the 1-for-70 reverse stock split effected on February 27, 2024
[2] Giving retroactive effect to the 1-for-70 reverse stock split effected on February 27, 2024